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Abstract
Numerous high-value proteins are secreted into the Escherichia coli periplasm by the
General Secretory (Sec) pathway, but Sec-based production chassis cannot
handle many potential target proteins. The Tat pathway offers a promising alternative
because it transports fully folded proteins; however, yields have been too low for
commercial use. To facilitate Tat export, we have engineered the TatExpress series of
super-secreting strains by introducing the strong inducible bacterial promoter, ptac,
upstream of the chromosomal tatABCD operon, to drive its expression in E. coli strains
commonly used by industry (e.g., W3110 and BL21). This modification significantly
improves the Tat-dependent secretion of human growth hormone (hGH) into the
bacterial periplasm, to the extent that secreted hGH is the dominant periplasmic
protein after only 1 hr induction. TatExpress strains accumulate in excess of 30mg L−1
periplasmic recombinant hGH, even in shake flask cultures. A second target protein, an
scFv, is also shown to be exported at much higher rates in TatExpress strains.
K E YWORD S
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1 | INTRODUCTION
The market for recombinant biopharmaceuticals such as antibody
fragments, growth factors, hormones, and other biologically based
medicines is estimated to be over $140 billion p.a., with antibody
products accounting for a large proportion of these sales (Walsh, 2014).
Over a third of currently licensed proteins are produced in E. coli, where
“secretion” out of the cytoplasm to the periplasm is a favored strategy.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
Douglas F. Browning and Kirsty L. Richards contributed equally to this work.
Biotechnology and Bioengineering. 2017;1–9. wileyonlinelibrary.com/journal/bit | 1
This minimizes downstream processing (DSP) costs because the target
protein can be purified from the relatively simple periplasmic contents,
and this strategy avoids debris andDNAcontamination,which are serious
DSP problems (Balasundaram, Harrison, & Bracewell, 2009). In addition,
most biopharmaceuticals contain disulfidebonds, and these canonly form
in the periplasm in Gram-negative bacteria.
Efficient E. coli secretion-based systems form the basis for a range of
industrial biopharmaceutical production platforms; however, many target
proteins fail to be exported to the periplasm because the standard export
method (via the Sec pathway) is only capable of transporting proteins in an
unfolded state (Natale, Bruser, & Driessen, 2008). Many heterologous
proteins pose problems due to rapid folding in the cytoplasm. However,
most bacteria possess a second protein export pathway, known as the Tat
pathway that has unique capabilities and two major advantages over the
standard Sec pathway. First, the Tat pathwayexports fully folded proteins,
and has already been shown to export a number of “Sec-incompatible”
heterologous molecules (DeLisa, Tullman, & Georgiou, 2003; Thomas,
Daniel, Errington, & Robinson, 2001). Moreover, the Tat system can
transport substratesup to150 kDa in sizeand it evenexports somenatural
substrates in a preassembled dimeric form; Tat therefore has clear
potential for export of relatively complex molecules (Rodrigue, Chanal,
Beck, Muller, & Wu, 1999). Secondly, the Tat pathway has an inbuilt
“quality control” system,whereby it preferentially exports correctly folded
proteins—it has been shown to secrete a range of heterologous proteins,
including several biopharmaceuticals (Alanen et al., 2015;
Matos et al., 2014), yet quantitatively reject virtually every misfolded
protein tested to date (DeLisa et al., 2003; Matos, Robinson, &
Di Cola, 2008; Richter & Bruser, 2005; Robinson et al., 2011). It thus
haspotential for theexportofcorrectly folded,highlyactive targetproteins
with minimal heterogeneity; that is, it simultaneously provides both a
means of exporting the product to the periplasm and increasing product
“quality,” thereby decreasing DSP costs.
To date, the Tat system has not been used for industrial secretion-
based strategies, primarily because product yields have been low. This is
partlyduetothe lowabundanceof theTatapparatuswhencomparedtothe
Sec system, which in turn reflects the fact that relatively few proteins are
naturally transported by the Tat system (Tullman-Ercek et al., 2007). It has
been shown that over-expression of the TatABC proteins from a second
plasmid can boost export of a heterologous target protein
(Matos et al., 2012), but the use of dual plasmids has clear disadvantages
for industrial applications (Barrett,Ray,Thomas,Robinson,&Bolhuis, 2003).
Here, we show that over-expression of the tatABC genes from the
chromosome leads to amajor enhancement of Tat export capacity, yielding
strains that have clear potential for industrial applications.
TABLE 1 Strains and plasmids used in this work.
Strains/plasmids Description Source/reference
W3110 E. coli K-12 strain. F− λ− IN(rrnD-rrnE)1 rph-1 Hayashi et al. (2006)
TatExpress W3110 Km1 W3110 carrying a kanamycin resistance cassette and the
ptac promoter upstream of tatABCD
This work
TatExpress W3110 W3110 carrying a ptac promoter upstream of tatABCD This work
BL21 E. coli B strain. fhuA2 [lon] ompT gal [dcm] ΔhsdS New England Biolabs, Hitchin, Hertfordshire, UK
TatExpress BL21 Km BL21 carrying a kanamycin resistance cassette and the
ptac promoter upstream of tatABCD
This work
TatExpress BL21 BL21 carrying a ptac promoter upstream of tatABCD This work
MC4100 AraR, F2 araD139 DlacU169 rpsL150 relA1 flB5301
deoC1 ptsF25 rbsR
Barrett et al. (2003)
ΔtatABCDE MC4100 strain lacking tatABCED genes, AraR Barrett et al. (2003)
pDOC-K Gene doctoring plasmid carrying ampicillin and kanamycin
resistance markers
Lee et al. (2009)
pDOC-ubiB pDOC-K carrying the ubiB homology region This work
pDOC-ubiB/tatA pDOC-K carrying the ubiB and tatA homology regions This work
pDOC-TatExpress pDOC-K carrying the ubiB and tatA homology regions
with the ptac promoter upstream of tatA
This work
pACBSR Gene recombineering plasmid which expresses the λ-Red
and I-SceI endonuclease genes and carries
chloramphenicol resistance
Herring et al. (2003)
pCP20 Temperature sensitive recombineering plasmid which
expresses the FLP recombinase and carries ampicillin
and chloramphenicol resistance
Cherepanov and Wackernagel (1995)
pEXT22 Protein over-expression vector carrying kanamycin
resistance
Dykxhoorn et al. (1996)
pEXT22/ tatABC pEXT22 expressing TatABC Barrett et al. (2003)
pKRK7 pEXT22 expressing TorA-hGH-6His This work
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2 | METHODS
2.1 | Bacterial strains, growth conditions,
plasmids, and primers
The bacterial strains and plasmids used in this work are listed in Table 1
and oligonucleotides are listed in Supplementary Table S1. Standard
methods for cloning and manipulating DNA fragments were used
throughout (Sambrook & Russell, 2001). Derivatives of pDOC-K
(Lee et al., 2009) and pCP20 (Cherepanov &Wackernagel, 1995) were
maintained in host cells using media supplemented with 100 μgml−1
ampicillin, pACBSR (Herring, Glasner, & Blattner, 2003) was main-
tained with 30 μgml−1 chloramphenicol and pEXT22 (Dykxhoorn,
St Pierre, & Linn, 1996) derivatives with 50 μgml−1 kanamycin. All
bacteria were cultured in LB medium (Sigma, Gillingham, Dorset, UK).
2.2 | Construction of TatExpress strains
To construct the TatExpress series of strains, in which ptac is inserted
upstream of the tatA promoter, gene doctoring methodology was used
(Lee et al., 2009) (Figure 1). Initially, theubiBhomology regionwas amplified
using PCRwith primers UbiBFw andUbiRev andW3110 genomic DNA as
FIGURE 1 Construction of the TatExpress strains. (a) The panel shows the construction of the E. coli K-12 TatExpress W3110 strain, using
gene doctoring (Lee et al., 2009). Plasmid pDOC-TatExpress was transformed into E. coli W3110 pACBSR and after induction of the SceI
meganuclease and λred gene expression (encoded for by pACSBR), the TatExpress gene cassette was transferred onto the W3110
chromosome by homologous recombination. The resultant TatExpress Km1 strain possesses a kanamycin resistance cassette and the ptac
promoter upstream of tatA and, thus, tatABCD operon expression is controlled by ptac and the tatA promoter (ptatA). The kanamycin
resistance cassette was removed by transforming cells with pCP20, expressing the Flp recombinase, to generate the TatExpress W3110
strain; (b) PCR analysis of the TatExpress W3110 strain. The panel shows an agarose gel of PCR products in which the ubiB-tatA region was
amplified from wild-type (WT) E. coli W3110 and TatExpress W3110; (c) Western blot analysis of W3110 TatExpress strains. The panel
shows a Western blot (top panel) and Coomassie blue strained SDS–PAGE gel (bottom panel) of normalized total cell protein from various
W3110 strains; (d) Western blot analysis of W3110 and TatExpress W3110, carrying derivatives of plasmid pEXT22. The panel shows a
Western blot (top panel) and Coomassie blue strained SDS–PAGE gel (bottom panel) of normalized total cell protein from W3110 and
TatExpress W3110 strains, carrying empty pEXT22 vector or pEXT22/ tatABC. In both (b) and (c) cells were grown in the presence (+) or
absence (−) of 1 mM IPTG and Western blots were probed with anti-TatA antiserum. Samples were calibrated by loading Page Ruler Plus
prestained markers in lane 1 (Thermo Scientific, Waltham, MA) and the location of TatA is indicated by an arrow
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template. Purified PCR product was restricted with EcoRI and HindIII and
cloned into the pDOC-K to generate pDOC-ubiB. The tatA homology
region, which carries the tatA promoter and the entire tatA open reading
frame, was amplified using PCR with primers TatAFw and TatARev and
W3110 genomic DNA template. PCR product was digested with NdeI and
SpeI and cloned into pDOC-ubiB, generating pDOC-ubiB/tatA. Finally the
ptacpromoter fromplasmidpEXT22 (Dykxhoornet al., 1996)was amplified
by PCR, using primers ptacXhoI and ptacNdeI and the product was
restrictedwithXhoI andNdeI andcloned intopDOC-ubiB/tatA togenerate
the gene doctoring plasmid pDOC-TatExpress. This places the ubiB
homology region and the ptac-tatA regions between the kanamycin
resistance cassette, encoded by the plasmid (Figure 1). The
pDOC-TatExpress plasmid was transformed into the E. coli K-12 strain
W3110, also carrying the gene doctoring plasmid pACBSR, and gene
doctoring was carried out as detailed in (Lee et al., 2009). Kanamycin
resistant colonies were isolated and the presence of the TatExpress
expression cassettewas confirmed in theTatExpressKm1strain, usingPCR
with primers ubiBFw(check) and tatBrev(check). The kanamycin resistance
cassette was removed by transforming candidates with plasmid pCP20 to
generate the strain TatExpressW3110. The ubiB/tatA region of kanamycin
sensitive candidates was amplified by PCR, using primers UbiBFw(check)
and tatBRev(check), and the purified PCR products were sequenced to
confirm strain construction. P1 transduction was used to transfer the
TatExpress cassette, still carrying its kanamycin resistance gene marker,
from E. coliK-12 TatExpress Km1 to E. coliBL21 (Thomason, Costantino, &
Court, 2007). Strain validation and the removal of the kanamycin resistance
cassette to generate strain TatExpress BL21 was as carried out as
detailed above.
2.3 | Construction of plasmids for protein
over-expression
Derivatives of the low copy number plasmid pEXT22 were used for
protein over-expression, and the pEXT22/hGH construct was
created by overlap extension PCR cloning (Bryksin & Matsumura,
2010). Primers pEXT22Up and pEXT22Down (Supplementary
Table S1) were used to PCR amplify the target gene of interest
from the pET23 based plasmid described in our previous work
(Alanen et al., 2015). The purified PCR product was then used as a
template in overlap extension PCR to generate the pEXT22/hGH
plasmid described in this study (Table 1). The protein amino acid
sequence of the expressed TorA-hGH protein and mature hGH
product are detailed in Supplementary Figure S1.
2.4 | Protein over-expression
Bacterial cultures were grown at 30°C with shaking in 100 ml of
LB medium, supplemented with 50 μg ml−1 kanamycin, until an
OD600 = 0.5 absorbance units (AU), after which protein
overexpression was induced by adding either 10 or 100 µm
IPTG (isopropyl β-D-1-thiogalactopyranoside). Samples were
taken for fractionation prior to induction, and at 1, 2, 3, 4,
and/or 5 hr post induction. Periplasmic (P) fractions were
collected using an EDTA/lysozyme/cold osmotic shock method
previously described (Pierce, Turner, Keshavarz-Moore, &
Dunnill, 1997; Randall & Hardy, 1986) and spheroplasts were
further fractionated into cytoplasmic (C) and membrane/insoluble
(M) fractions as described in (Pierce et al., 1997).
2.5 | Sample preparation, protein detection, and
quantitation
The preparation of normalized protein samples were carried out as
detailed in our previous work (Alanen et al., 2015; Browning et al., 2013).
Protein samples were resolved by reducing SDS–PAGE and analyzed
usingCoomassieblue stainingandWesternblotting. ForWesternblotting
E. coliTatAproteinwasdetectedusinganti-TatAantiserumraised in rabbit
and an anti-rabbit-HRP secondary antibody (Promega, Southampton,
Hertfordshire, UK), and detection of C-terminal-His6 tagged proteins
using anti-His6 (C-terminal) raised inmouse (Invitrogen, Life Technologies
Ltd, Paisley, Renfrewshire, UK) and an anti-mouse-HRP secondary
antibody (Promega). Blots were developed using Clarity Western ECL
substrate (Bio-Rad, Hemel Hempstead, Hertfordshire, UK) and images
collected using a Bio-Rad ChemiDoc XRS+ molecular imager. All gels and
blots shown are representative. Quantitation was carried out using Bio-
Rad Image Lab software and calculated using an average of two gels or
blots (within linear range) of biological triplicates against a standard curve
of purifiedhGH-His6. Periplasmic hGHwasassayedusing ahGHELISAkit
as per the manufacturer's protocol (Roche Diagnostics, Charles Ave,
Burgess Hill, West Sussex RH15 9RY). Standardized OD10 periplasmic
fractions were diluted 1:500,000 using PBS and absorbance was read
using a BMG Labtech Spectrostar microplate reader at 405 nm, with a
reference wavelength at 490 nm. Concentrations were calculated from
two independent experiments and all samplesmeasured in duplicate, and
used tocalculateaverageperiplasmicyield (inmg/L) by factoring in culture
OD readings at 600 nm.
3 | RESULTS
3.1 | Construction of TatExpress strains of E. coli
Previously,wedemonstrated thatoverexpressionofTatABCfromthe low
copy number plasmid pEXT22/tatABC yielded amild improvement in the
secretion of a recombinant protein bearing a Tat peptide (Branston,
Matos, Freedman, Robinson, & Keshavarz-Moore, 2012). In order to
minimize the use of antibiotics, and the metabolic burden on cells, we
engineered a plasmid-free system. Thus, we introduced the strong tac
promoter (ptac), which is regulated by the LacI repressor and IPTG
(isopropyl β-D-1-thiogalactopyranoside), upstream of the chromosomal
tatABCD operon in E. coli strainsW3110 and BL21, using gene doctoring
methodology (Lee et al., 2009). To accomplish this we generated the
plasmidpDOC-TatExpress,which carriesptac and a kanamycin resistance
cassette flankedby the tatA andubiB chromosomal sequences (Figure 1a).
This expression cassette was crossed onto theW3110 chromosome, and
removal of the kanamycin cassette generated strain TatExpress W3110,
inwhich tatABCDexpression is controlledbyboth theptacandnative tatA
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promoters (ptatA) (Figure 1a). PCR analysis and DNA sequencing
confirmed correct strain construction (Figure 1b and Supplementary
Figure S2) andWestern blotting of normalized total protein samples with
anti-TatA antiserum demonstrated that the expression of TatA in
TatExpress W3110 was considerably higher than wild-type (WT)
W3110 (Figure 1c) and exceeded that produced by W3110 carrying
pEXT22/tatABC (Figure 1d, lanes 6 and 7). IPTG-dependent control of
TatAexpression inTatExpressW3110was also achievedbyproviding the
lacIq gene, which is carried by the empty pEXT22 vector (Figure 1d, lanes
10 and 11). Similar high-level expression of TatA was also achieved with
the equivalent BL21 strain TatExpress BL21 (Supplementary Figure S3).
Growth of both TatExpress derivatives was indistinguishable
from their respective WT strains in shake-flask cultures using
standard LB medium (Figure 2). Similarly, the TatExpress strains
showed no growth inhibition in tests using a variety of other media
(data not shown). Thus, we have engineered a series of industrially
relevant E. coli strains to express tatABCD to high levels. Additional
experiments identified the optimal IPTG concentration for export
of hGH in each strain (data not shown), and the strains’ export
capacities were tested using a construct in which mature hGH was
expressed with an N-terminal TorA signal peptide and a C-terminal
hexa-histidine tag (His6) from a pEXT22 based plasmid.
3.2 | TatExpress strains exhibit enhanced export of
hGH and an scFv
Figure 3 illustrates the expression and export of TorA-hGH in WT
E. coli W3110 cells and the TatExpress W3110 strain; expression
was induced using 10 µm IPTG and cells were fractionated
immediately prior to induction, and at 1, 2, 3, and 4 hr post
induction, into cytoplasm, membrane/insoluble, and periplasm
samples (C, M, P). Fractionated samples were analyzed by
Coomassie stained reducing SDS–PAGE (Figures 3a and 3b) and
by immunoblotting periplasmic samples using anti-His6 anti-
bodies (Figure 3c). The immunoblot (Figure 3c) shows that hGH is
efficiently exported to the periplasm in WT cells, as observed
previously (Alanen et al., 2015). Export in TatExpress W3110 cells
is, however, considerably more efficient, with a >5-fold enhance-
ment found in TatExpress cells. The Coomassie gels provide a
measure of the abundance of the exported protein. In WT cells,
the periplasmic hGH is visible after 2 hr of induction (arrow) and
by the end of 4 hr induction it is clearly visible within the
periplasmic fraction (Figure 3a). However, export of TorA-hGH is
much more efficient in TatExpress W3110 cells and it is notable
that, by the end of the 4 hr induction, hGH is the second most
abundant protein in the periplasm. The identity of the hGH band
was confirmed using mass spectrometry (Supplementary
Figure S4). Mature hGH is the second most prominent band
after the 61.5 kDa OppA protein, a periplasmic subunit of an
oligopeptide ABC transporter required for peptide uptake (and
strongly induced by growth in LB media). Quantitation of
immunoblots using a hGH-His6 protein standard show that
average periplasmic export levels are 14.5 mg L−1, with the
cultures reaching OD600 values of 2.5 AU after 4 hr induction.
Similar tests using TatExpress BL21 cells are shown in Figure 4.
Here, expression was induced with 100 µm IPTG and cells were
analyzed before induction, and at 1, 3, and 5 hr post induction.
Immunoblotting analysis of periplasmic fractions (Figure 4a) shows
the appearance of mature hGH after 1 hr induction, and the data
show that TatExpress cells exhibit a major increase in hGH export
(a 4.8-fold increase was calculated by densitometry). SDS–PAGE
analysis of TatExpress BL21 cells (Figure 4b) shows that export is
clearly evident at 1 hr post induction, with a substantial periplasmic
hGH band visible (arrowed). Export proceeds during the 5 hr
induction, and by the end of the induction period hGH is by far the
most prominent periplasmic band. Quantitation of the immuno-
blots shows that the TatExpress BL21 cells export 31 mg L−1 of
hGH to the periplasm, with the cultures reaching OD600 values of
2.5 AU after 5 hr induction. Separate quantitation using a
commercial hGH ELISA test (see section 2) gave a figure of
22 mg L−1 hGH.
Similar tests were carried out using a second target molecule: a
single chain antibody fragment (scFv) that has been previously shown
to be efficiently exported by Tat if a TorA signal peptide is attached
(Alanen et al., 2015). This construct was expressed in WTW3110 and
BL21 strains, and in the TatExpress variants (W3110 TE and BL21 TE)
and export assays were carried out after 3, 4, and 5 hr induction. The
periplasmic fractions were immunoblotted to detect the export scFv
(Figure 5). In some cases the cells exhibit lowered export by the 5 hr
time point, which reflects the onset of stress as the cells go into
stationary phase, but the data for the 3 and 4 hr time points show a
FIGURE 2 Growth characteristics of W3110 WT and TatExpress
strains. The figure shows representative growth curves of W3110
WT and TatExpress strains. All bacterial strains carry the pKRK7
plasmid encoding TorA-hGH and were grown in 50ml of LB
medium with shaking at 37°C. Induction took place at the 3 hr
growth point (approximately 0.5 AU). The graphs are for uninduced
W3110 WT and TatExpress (white diamonds and white squares,
respectively), and induced W3110 WT and TatExpress (black
diamonds and squares, respectively)
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consistent picture: both theW3110 and BL21 TatExpress strains show
a very marked enhancement of export when compared with the
WT strains.
3.3 | Optimization of induction protocol is a
key factor in the high-level export capacity of
TatExpress strains
A significant point to emerge from these studies is that optimal results
are only achieved by matching the synthesis of the substrate to the Tat
system's export capacity. This is illustrated by Figure 6, which shows the
effects of increasing IPTG concentration from10µm to 1mmon export
efficiency and growth characteristics of the TatExpress W3110 strain.
Figure 6a shows that, while efficient export of hGH to the periplasm is
observed at all of the IPTG concentraions, the lowest concentration of
IPTG actually yields the highest level of mature hGH in the periplasm.
We believe that the higher IPTG concentrations do generate more
protein product, as would be expected, but that the “excess” hGH is
degraded if the Tat system is unable to export it. hGH appears to be
particularly susceptible to degradation by cytoplasmic proteases;
Supplementary Figure S5 shows that expression of TorA-hGH in a
different strain, MC4100, leads to efficient export to the periplasm
whereas expression in theΔtat strain leads to an almost complete loss of
protein. In contrast, cytoplasmic expression of TorA-scFv is readily
apparent in Δtat cells. Figure 6b shows that raising the concentration of
FIGURE 3 Tat-dependent export of TorA-hGH in W3110 and TatExpress W3110 cells. Coomassie blue stained 12.5% SDS-PAGE gels
showing the export of mature hGH (22 kDa, arrowed) into the periplasm of W3110 wild-type (a) and TatExpress W3110; (b) cells pre-
and post-induction using 10 µm IPTG; (c) Western blot of periplasmic samples from (a) and (b) probed using anti-C-terminal-His6 antibody.
TatExpress W3110 cells show a >5 increase in exported protein at 4 hr post induction relative to export in wild-type cells. Labels are as
follows: C, cytoplasmic fraction; M, membrane and insoluble fraction; P, periplasmic fraction; Pre, pre-induction; PI, post-induction. For
each lane a normalized amount of protein has been loaded, equivalent to OD600 0.08 AU total cells (Coomassie blue stained gels), and
OD600 0.008 AU (immunoblots)
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IPTG also leads to a progressive inhibition of growth,which is consistent
with the excess target protein leading to cell stress.
4 | DISCUSSION
The Tat system's potential as a biotechnological platform has
been reported in several studies but low secretion rates have
been a serious barrier to industrial exploitation. To our
knowledge, no heterologous protein has been exported by Tat
to the extent that it ranks among the major periplasmic proteins
by the end of the culture period. In this study we have generated
super-secreting strains by (i) generating strains that stably
overexpress the Tat system from the chromosome and (ii)
matching target protein expression levels to the Tat secretion
capacity of the cell. Our results clearly show that combined
high-level expression of both the Tat system and recombinant
hGH protein leads to the formation of inclusion bodies and/or
degradation of the precursor protein. Lower level expression
from a low copy number plasmid, together with induction using
an optimal concentration of IPTG, leads to much more efficient
secretion rates. The net result is a platform that exports hGH by
the Tat pathway at extremely high rates, to the extent that the
target protein is the most abundant periplasmic protein within a
few hours of induction. The system is also capable of exporting
high levels of other proteins, for example a previously tested
single chain antibody fragment (Alanen et al., 2015) at high
levels.
This platform has clear uses for large scale protein production
in fed-batch fermentation systems, and future studies will assess
its potential in fed-batch fermentation systems that more closely
mimic industrial production processes. However, it should also be
noted that even this simple shake-flask system has the ability to
FIGURE 4 Export of TorA-hGH in BL21 and TatExpress BL21 cells. (a) immunoblot showing showing the accumulation of mature hGH
(22 kDa) in the periplasm of BL21 wild-type cells and TatExpress BL21 cells upon the induction of protein over-expression by the addition of
100 µm IPTG. Periplasmic samples were analyzed pre-induction (Pre) and after 1, 3, and 5 induction; (b) Coomassie-stained gel of cytoplasmic
fractions, membrane and insoluble fractions and periplasmic fractions (C, M, P) from TatExpress BL21 cells expressing TorA-hGH. Samples
were analyzed pre-induction (Pre) and 1, 3, and 5 hr post-iduction (PI). For each lane a normalized amount of protein has been loaded,
equivalent to OD600 0.08 AU total cells
FIGURE 5 An scFv is exported in significantly higher quantities in
TatExpress cells. A construct comprising an scFv bearing a TorA
signal peptide was expressed in WT W3110 and BL21 cells, and in
the TatExpress versions, as carried out with TorA-hGH in Figures 3
and 4. After induction for 3 hr, cells were fractionated and blotted
as described in Figures 3 and 4
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generate quantities of protein (tens of mg) that are sufficient for
many purposes.
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